Xvivo Perfusion AB (XVIPF)
30.95
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Xvivo Perfusion EPS Diluted (Quarterly) : 0.0552 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0552 |
| March 31, 2026 | 0.1258 |
| December 31, 2025 | 0.1066 |
| September 30, 2025 | 0.0145 |
| June 30, 2025 | 0.0052 |
| March 31, 2025 | -0.0369 |
| December 31, 2024 | 0.1066 |
| September 30, 2024 | 0.2599 |
| June 30, 2024 | 0.0805 |
| March 31, 2024 | 0.0696 |
| December 31, 2023 | 0.2038 |
| September 30, 2023 | 0.007 |
| June 30, 2023 | 0.0219 |
| March 31, 2023 | 0.0455 |
| December 31, 2022 | 0.0023 |
| September 30, 2022 | 0.0173 |
| June 30, 2022 | 0.0259 |
| March 31, 2022 | 0.0171 |
| December 31, 2021 | 0.0464 |
| September 30, 2021 | -0.0045 |
| June 30, 2021 | -0.037 |
| March 31, 2021 | 0.0244 |
| December 31, 2020 | -0.0791 |
| September 30, 2020 | -0.0579 |
| June 30, 2020 | -0.0622 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0254 |
| December 31, 2019 | -0.0074 |
| September 30, 2019 | 0.0191 |
| June 30, 2019 | 0.0088 |
| March 31, 2019 | -0.0013 |
| December 31, 2018 | 0.0205 |
| September 30, 2018 | 0.0004 |
| June 30, 2018 | 0.0173 |
| March 31, 2018 | 0.0185 |
| December 31, 2017 | 0.0252 |
| September 30, 2017 | -0.0012 |
| June 30, 2017 | 0.0045 |
| March 31, 2017 | -0.0002 |
| December 31, 2016 | -0.0022 |
| September 30, 2016 | -0.0023 |
| June 30, 2016 | 0.0085 |
| March 31, 2016 | 0.0059 |
| December 31, 2015 | 0.0153 |
| September 30, 2015 | 0.0059 |
| June 30, 2015 | 0.0071 |
| March 31, 2015 | -0.006 |
| December 31, 2014 | -0.0013 |
| September 30, 2014 | 0.0101 |
| June 30, 2014 | 0.0061 |
| March 31, 2014 | 0.0139 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Getinge AB | 0.3297 |
| Paxman AB | 0.0117 |
| Enovis Corp. | -0.0207 |
| Edwards Lifesciences Corp. | 0.4188 |
| Intuitive Surgical, Inc. | 2.290 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.739M |
| Revenue (Quarterly) | 25.52M |
| Total Expenses (Quarterly) | 23.78M |
| Enterprise Value | 955.97M |
| Gross Profit Margin (Quarterly) | 63.23% |
| Profit Margin (Quarterly) | 6.81% |
| Earnings Yield | 0.98% |
| Operating Earnings Yield | 1.19% |
| Normalized Earnings Yield | 0.9738 |